The emergence of vancomycin‐intermediate and vancomycin‐resistant Staphylococcus aureus

PC Appelbaum - Clinical Microbiology and Infection, 2006 - Wiley Online Library
Methicillin‐resistant Staphylococcus aureus (MRSA) is well‐recognised as a major cause of
infection in the healthcare setting but, even more worryingly, is now emerging in the …

High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity

LK Hidayat, DI Hsu, R Quist, KA Shriner… - Archives of internal …, 2006 - jamanetwork.com
Background Vancomycin hydrochloride treatment failure for infections caused by
susceptible methicillin-resistantStaphylococcus aureus (MRSA) strains with high minimum …

Clinical, Epidemiological, and Laboratory Aspects of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections

E Palavecino - Methicillin-Resistant Staphylococcus aureus (MRSA) …, 2007 - Springer
Methicillin-resistant Staphylococcus aureus (MRSA) is a major pathogen responsible for
both hospital-and community-onset disease. Resistance to methicillin in S. aureus is …

Survival and transmission of community-associated methicillin-resistant Staphylococcus aureus from fomites

R Desai, PS Pannaraj, J Agopian, CA Sugar… - American journal of …, 2011 - Elsevier
Background Transmission of community-associated methicillin-resistant Staphylococcus
aureus (CA-MRSA) from fomites appears to play an important role in CA-MRSA outbreaks …

Staphylococcus aureus: the reemergence of a pathogen in the community

JA Bustos-Martínez, A Hamdan-Partida… - Revista …, 2006 - medigraphic.com
Staphylococcus aureus is a particularly virulent microorganism that is resistant to antibiotics.
It can cause a wide variety of diseases in man. The main impact of this microorganism is due …

Treatment of Infections Due to Resistant Staphylococcus aureus

GM Anstead, J Cadena, H Javeri - Methicillin-Resistant Staphylococcus …, 2014 - Springer
This chapter reviews data on the treatment of infections caused by drug-resistant
Staphylococcus aureus, particularly methicillin-resistant S. aureus (MRSA). This review …

Antimicrobial characterisation of solithromycin (CEM-101), a novel fluoroketolide: activity against staphylococci and enterococci

SD Putnam, HS Sader, DJ Farrell… - International journal of …, 2011 - Elsevier
Solithromycin (CEM-101) is a novel fluoroketolide with high potency against Gram-positive
and Gram-negative bacteria commonly associated with community-acquired respiratory tract …

Complex host genetic susceptibility to Staphylococcus aureus infections

SK Shukla, W Rose, SJ Schrodi - Trends in microbiology, 2015 - cell.com
Understanding of the host genetic susceptibility to carriage of, and infections, due to
Staphylococcus aureus, a nosocomial pathogen, is still in its nascent stages. Mouse models …

[HTML][HTML] Nosocomial infections and drug susceptibility patterns in methicillin sensitive and methicillin resistant Staphylococcus aureus

NK Sharma, R Garg, S Baliga… - Journal of clinical and …, 2013 - ncbi.nlm.nih.gov
Aim: Staphylococcus aureus is one of the leading causes of nosocomial infections and is
known for its ability to develop resistance to antibiotics. The drug susceptibility pattern of …

Antibiotic resistance in the environment, with particular reference to MRSA

W Gaze, C O'Neill, E Wellington, P Hawkey - Advances in applied …, 2008 - Elsevier
Publisher Summary The evolution of antibiotic resistant bacteria is one of the most
significant problems in modern medicine and poses a serious threat to human health …